Market Outlook
The global Activin-A market size was valued at USD 14 million in 2022 and is forecast to a readjusted size of USD 32 million by 2029 with a CAGR of 12.0% during review period.
Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological activities, including mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis and roles in reproductive physiology. Activin isoforms and other members of the TGF-beta superfamily exert their biological effects by binding to heteromeric complexes of a type I and a type II serine-threonine kinase receptor, both of which are essential for signal transduction.
Major players in the industry are Merck Millipore, Thermo Fisher Scientific and bio-techne, which accounted for 26.80%, 12.00% and 10.32% of revenue in 2019, respectively. By region, North America has the highest share of income, at 52.22 percent in 2019.
This report is a detailed and comprehensive analysis for global Activin-A market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Activin-A market size and forecasts, in consumption value ($ Million), sales quantity (mg), and average selling prices (US$/mg), 2018-2029
Global Activin-A market size and forecasts by region and country, in consumption value ($ Million), sales quantity (mg), and average selling prices (US$/mg), 2018-2029
Global Activin-A market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (mg), and average selling prices (US$/mg), 2018-2029
Global Activin-A market shares of main players, shipments in revenue ($ Million), sales quantity (mg), and ASP (US$/mg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Activin-A
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Activin-A market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Merck Millipore
Thermo Fisher Scientific
Bio-Techne
StemRD
Prospec
Proteintech Group
Ajinomoto
Enzo Life Sciences
IBL
STEMCELL
Sino Biological
PeproTech
ReproCELL
Segmentation By Type
Activin-A Human
Activin-A Mouse(Rat)
Segmentation By Application
Commercial Research
Academic Research
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Activin-A market in 2025?
The Activin-A market is expected to benefit from increasing applications in biopharmaceuticals, particularly in regenerative medicine and rare disease treatments. Strong research and development activity, along with the growing focus on personalized medicine, will likely drive market growth. Additionally, its potential in addressing fibrosis and inflammatory diseases offers a unique therapeutic opportunity.
What are the weaknesses in the Activin-A market in 2025?
The Activin-A market faces challenges related to high production costs, regulatory hurdles, and limited market awareness compared to more established biopharmaceutical products. Its complex molecular properties may also hinder widespread commercialization and development, as extensive clinical trials and validation are required.
What are the opportunities for the Activin-A market in 2025?
Opportunities exist in expanding research into its role in treating conditions like cardiovascular diseases, autoimmune disorders, and cancers. Moreover, as the demand for precision medicine grows, the ability to develop targeted treatments with Activin-A could capture significant market share, particularly in niche therapeutic areas.
What are the threats to the Activin-A market in 2025?
Competitive threats from other therapeutic proteins and biopharmaceutical innovations could challenge Activin-A’s market position. Furthermore, the potential for stringent regulatory policies, alongside the risk of delayed clinical trial outcomes, may slow its adoption in various therapeutic sectors.
Market PESTEL Analysis
What are the political factors affecting the Activin-A market in 2025?
Political factors include the impact of healthcare policies and regulations that govern biopharmaceutical development. Government support for research funding and initiatives to promote regenerative medicine can enhance market growth. However, changes in administration and shifts in policy priorities may create uncertainty for companies operating in this space.
What are the economic factors influencing the Activin-A market in 2025?
Economic factors such as the overall growth of the biopharmaceutical sector and investment levels in healthcare R&D will play a significant role. Fluctuations in healthcare budgets and spending, along with the availability of funding for research and development, could affect the pace of innovation and market entry for Activin-A products.
What are the social factors impacting the Activin-A market in 2025?
Social factors include the rising public awareness and acceptance of biopharmaceuticals, particularly those targeting specific diseases. Increasing prevalence of chronic diseases and an aging population will likely drive demand for innovative treatments. Moreover, patient advocacy groups pushing for advanced therapies can influence market dynamics positively.
What are the technological factors shaping the Activin-A market in 2025?
Technological advancements in biotechnology, including improved methods for producing and analyzing proteins, will enhance the development of Activin-A therapies. Innovations in drug delivery systems and personalized medicine technologies will also facilitate more effective treatment options, potentially increasing market adoption.
What are the environmental factors affecting the Activin-A market in 2025?
Environmental factors include the growing emphasis on sustainable practices in biopharmaceutical manufacturing. Companies may face pressure to adopt eco-friendly production methods and comply with regulations aimed at reducing environmental impact. The increasing focus on sustainability could influence investment and operational strategies in the Activin-A market.
What are the legal factors that may influence the Activin-A market in 2025?
Legal factors encompass intellectual property rights, patent laws, and compliance with regulatory standards in drug development. Robust patent protections can encourage investment in Activin-A research, while potential legal challenges related to patent infringements could pose risks. Additionally, adherence to regulatory requirements is crucial for successful market entry and product approval.
Market SIPOC Analysis
Who are the suppliers in the Activin-A market in 2025?
Suppliers in the Activin-A market include biotechnology companies that produce recombinant proteins, raw material suppliers for biomanufacturing, and contract research organizations (CROs) that offer research and development services. Additionally, suppliers of specialized equipment and technologies for production and analysis also play a crucial role.
What are the inputs required for the Activin-A market in 2025?
Inputs for the Activin-A market involve high-quality raw materials for protein synthesis, such as cell cultures, growth factors, and reagents for bioprocessing. Furthermore, research and development data, regulatory compliance documentation, and clinical trial results are essential inputs for successful product development and commercialization.
What are the processes involved in the Activin-A market in 2025?
Key processes in the Activin-A market include research and development, protein engineering, clinical trial management, regulatory submission, and commercialization. Additionally, processes for manufacturing, quality assurance, and supply chain management are critical to ensure product safety and efficacy.
Who are the customers of the Activin-A market in 2025?
Customers in the Activin-A market encompass pharmaceutical companies seeking innovative therapeutic options, healthcare providers looking for advanced treatment solutions, and research institutions conducting studies on regenerative medicine. Patients suffering from conditions treatable with Activin-A therapies are also key stakeholders in this market.
What are the outputs of the Activin-A market in 2025?
Outputs of the Activin-A market include biopharmaceutical products aimed at treating various diseases, such as fibrosis, autoimmune disorders, and cancer. Additionally, scientific publications, clinical trial data, and reports on product efficacy and safety contribute to the body of knowledge in regenerative medicine and the overall advancement of the field.
Market Porter's Five Forces
How intense is the competitive rivalry in the Activin-A market in 2025?
The competitive rivalry is moderate to high, with established biopharmaceutical companies and emerging biotech firms actively investing in research and development. Companies competing in this space focus on innovation, clinical trial success, and regulatory approvals to gain market advantage. Differentiation through novel applications and strategic partnerships plays a crucial role in staying competitive.
How strong is the threat of new entrants in the Activin-A market in 2025?
The threat of new entrants is moderate due to high barriers such as stringent regulatory requirements, significant research and development costs, and the need for specialized expertise. However, advancements in biotechnology and increasing investment in personalized medicine may encourage new players to enter the market, particularly startups and niche biotech firms.
How much bargaining power do suppliers have in the Activin-A market in 2025?
Suppliers hold moderate bargaining power as Activin-A production relies on specialized raw materials, bioprocessing technologies, and expertise in protein engineering. Limited suppliers for high-quality biopharmaceutical ingredients and advanced biomanufacturing equipment can influence pricing and availability, impacting production costs for companies.
How strong is the bargaining power of buyers in the Activin-A market in 2025?
Buyers, including pharmaceutical companies, healthcare providers, and research institutions, have moderate to high bargaining power. They demand high efficacy, safety, and cost-effectiveness in Activin-A products. Competitive pricing, clinical trial data, and regulatory approvals play a key role in influencing purchasing decisions.
How significant is the threat of substitutes in the Activin-A market in 2025?
The threat of substitutes is moderate, as alternative biopharmaceutical therapies, including other growth factors, cytokines, and gene therapies, may offer similar therapeutic benefits. However, Activin-A’s unique biological functions and potential in regenerative medicine and targeted therapies help it maintain a competitive position in specialized treatment areas.
Market Upstream Analysis
What are the key upstream components in the Activin-A market in 2025?
The key upstream components include raw materials such as recombinant protein sources, cell culture media, growth factors, and reagents necessary for protein synthesis. Advanced biomanufacturing equipment, bioreactors, and purification systems are also critical for production.
Who are the major suppliers in the upstream Activin-A market in 2025?
Major suppliers include biotechnology firms specializing in recombinant protein production, manufacturers of bioprocessing equipment, and providers of specialized reagents and cell culture media. Contract research organizations (CROs) and contract manufacturing organizations (CMOs) also play a role in supplying research and production capabilities.
What are the major challenges in the upstream Activin-A supply chain in 2025?
Challenges include the high cost of raw materials, limited availability of specialized reagents, and complex regulatory requirements for biopharmaceutical production. Supply chain disruptions, such as shortages of key components or geopolitical factors, can also impact production timelines and costs.
How does technological advancement impact the upstream Activin-A market in 2025?
Technological advancements improve the efficiency and scalability of Activin-A production through innovations in bioprocessing, synthetic biology, and precision fermentation. Automation and AI-driven process optimization help enhance yield, reduce costs, and maintain high-quality standards.
What role do regulatory agencies play in the upstream Activin-A market in 2025?
Regulatory agencies set strict guidelines for raw material sourcing, production processes, and quality control to ensure product safety and efficacy. Compliance with Good Manufacturing Practices (GMP) and approval from agencies like the FDA and EMA is essential for successful upstream operations.
Market Midstream Analysis
What are the key midstream activities in the Activin-A market in 2025?
Key midstream activities include the production and purification processes of Activin-A, quality control testing, and formulation development. These activities ensure that the product meets regulatory standards and maintains its biological activity, stability, and efficacy for therapeutic applications.
Who are the primary stakeholders involved in midstream operations in the Activin-A market in 2025?
Primary stakeholders include biopharmaceutical companies engaged in the development and manufacturing of Activin-A products, contract manufacturing organizations (CMOs) responsible for production, and quality assurance teams that oversee compliance with regulatory requirements. Additionally, research institutions may also be involved in midstream activities related to clinical trials and product testing.
What are the major challenges in the midstream Activin-A market in 2025?
Major challenges include maintaining consistent quality and yield during production, adhering to stringent regulatory requirements, and managing the complexities of large-scale manufacturing. Moreover, the need for advanced purification techniques to isolate high-quality Activin-A can present technical difficulties and increase operational costs.
How does technology influence midstream operations in the Activin-A market in 2025?
Technology significantly influences midstream operations through advancements in bioprocessing techniques, automation, and data analytics. Innovations in downstream processing, such as improved chromatography and filtration methods, enhance the efficiency and effectiveness of Activin-A purification and formulation processes.
What regulatory considerations impact midstream activities in the Activin-A market in 2025?
Regulatory considerations include compliance with Good Manufacturing Practices (GMP), documentation of production processes, and rigorous quality control measures. Regulatory agencies require detailed data on product safety, efficacy, and manufacturing processes to ensure that Activin-A products meet the necessary standards for clinical use and commercialization.
Market Downstream Analysis
What are the key downstream activities in the Activin-A market in 2025?
Key downstream activities include the distribution, marketing, and commercialization of Activin-A-based products. These activities ensure the product reaches pharmaceutical companies, healthcare providers, and research institutions for therapeutic and diagnostic applications.
Who are the primary customers in the downstream Activin-A market in 2025?
Primary customers include pharmaceutical and biotech companies developing targeted therapies, hospitals and clinics using Activin-A for specialized treatments, and research institutions conducting clinical studies. Regulatory agencies and healthcare policymakers also play a role in influencing adoption and market expansion.
What are the major challenges in the downstream Activin-A market in 2025?
Challenges include market competition from alternative biopharmaceuticals, pricing pressures, and regulatory hurdles that may delay commercialization. Additionally, ensuring a stable supply chain and addressing reimbursement concerns can impact market penetration.
How does distribution impact the downstream Activin-A market in 2025?
Efficient distribution networks are crucial for ensuring timely delivery to end-users, maintaining product stability, and complying with regulatory requirements. Cold-chain logistics and strategic partnerships with pharmaceutical distributors help optimize supply chain efficiency.
What role do regulatory approvals play in the downstream Activin-A market in 2025?
Regulatory approvals are essential for market entry, as agencies like the FDA and EMA evaluate safety, efficacy, and manufacturing compliance. Delays in approval processes can slow commercialization, while successful approvals can enhance market credibility and adoption.
Chapter 1, to describe Activin-A product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Activin-A, with price, sales, revenue and global market share of Activin-A from 2018 to 2023.
Chapter 3, the Activin-A competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Activin-A breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Activin-A market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Activin-A.
Chapter 14 and 15, to describe Activin-A sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Activin-A
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Activin-A Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Activin-A Human
1.3.3 Activin-A Mouse(Rat)
1.4 Market Analysis by Application
1.4.1 Overview: Global Activin-A Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Commercial Research
1.4.3 Academic Research
1.5 Global Activin-A Market Size & Forecast
1.5.1 Global Activin-A Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Activin-A Sales Quantity (2018-2029)
1.5.3 Global Activin-A Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck Millipore
2.1.1 Merck Millipore Details
2.1.2 Merck Millipore Major Business
2.1.3 Merck Millipore Activin-A Product and Services
2.1.4 Merck Millipore Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Millipore Recent Developments/Updates
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Activin-A Product and Services
2.2.4 Thermo Fisher Scientific Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Scientific Recent Developments/Updates
2.3 Bio-Techne
2.3.1 Bio-Techne Details
2.3.2 Bio-Techne Major Business
2.3.3 Bio-Techne Activin-A Product and Services
2.3.4 Bio-Techne Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bio-Techne Recent Developments/Updates
2.4 StemRD
2.4.1 StemRD Details
2.4.2 StemRD Major Business
2.4.3 StemRD Activin-A Product and Services
2.4.4 StemRD Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 StemRD Recent Developments/Updates
2.5 Prospec
2.5.1 Prospec Details
2.5.2 Prospec Major Business
2.5.3 Prospec Activin-A Product and Services
2.5.4 Prospec Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Prospec Recent Developments/Updates
2.6 Proteintech Group
2.6.1 Proteintech Group Details
2.6.2 Proteintech Group Major Business
2.6.3 Proteintech Group Activin-A Product and Services
2.6.4 Proteintech Group Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Proteintech Group Recent Developments/Updates
2.7 Ajinomoto
2.7.1 Ajinomoto Details
2.7.2 Ajinomoto Major Business
2.7.3 Ajinomoto Activin-A Product and Services
2.7.4 Ajinomoto Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Ajinomoto Recent Developments/Updates
2.8 Enzo Life Sciences
2.8.1 Enzo Life Sciences Details
2.8.2 Enzo Life Sciences Major Business
2.8.3 Enzo Life Sciences Activin-A Product and Services
2.8.4 Enzo Life Sciences Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Enzo Life Sciences Recent Developments/Updates
2.9 IBL
2.9.1 IBL Details
2.9.2 IBL Major Business
2.9.3 IBL Activin-A Product and Services
2.9.4 IBL Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 IBL Recent Developments/Updates
2.10 STEMCELL
2.10.1 STEMCELL Details
2.10.2 STEMCELL Major Business
2.10.3 STEMCELL Activin-A Product and Services
2.10.4 STEMCELL Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 STEMCELL Recent Developments/Updates
2.11 Sino Biological
2.11.1 Sino Biological Details
2.11.2 Sino Biological Major Business
2.11.3 Sino Biological Activin-A Product and Services
2.11.4 Sino Biological Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sino Biological Recent Developments/Updates
2.12 PeproTech
2.12.1 PeproTech Details
2.12.2 PeproTech Major Business
2.12.3 PeproTech Activin-A Product and Services
2.12.4 PeproTech Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 PeproTech Recent Developments/Updates
2.13 ReproCELL
2.13.1 ReproCELL Details
2.13.2 ReproCELL Major Business
2.13.3 ReproCELL Activin-A Product and Services
2.13.4 ReproCELL Activin-A Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ReproCELL Recent Developments/Updates
3 Competitive Environment: Activin-A by Manufacturer
3.1 Global Activin-A Sales Quantity by Manufacturer (2018-2023)
3.2 Global Activin-A Revenue by Manufacturer (2018-2023)
3.3 Global Activin-A Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Activin-A by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Activin-A Manufacturer Market Share in 2022
3.4.2 Top 6 Activin-A Manufacturer Market Share in 2022
3.5 Activin-A Market: Overall Company Footprint Analysis
3.5.1 Activin-A Market: Region Footprint
3.5.2 Activin-A Market: Company Product Type Footprint
3.5.3 Activin-A Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Activin-A Market Size by Region
4.1.1 Global Activin-A Sales Quantity by Region (2018-2029)
4.1.2 Global Activin-A Consumption Value by Region (2018-2029)
4.1.3 Global Activin-A Average Price by Region (2018-2029)
4.2 North America Activin-A Consumption Value (2018-2029)
4.3 Europe Activin-A Consumption Value (2018-2029)
4.4 Asia-Pacific Activin-A Consumption Value (2018-2029)
4.5 South America Activin-A Consumption Value (2018-2029)
4.6 Middle East and Africa Activin-A Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Activin-A Sales Quantity by Type (2018-2029)
5.2 Global Activin-A Consumption Value by Type (2018-2029)
5.3 Global Activin-A Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Activin-A Sales Quantity by Application (2018-2029)
6.2 Global Activin-A Consumption Value by Application (2018-2029)
6.3 Global Activin-A Average Price by Application (2018-2029)
7 North America
7.1 North America Activin-A Sales Quantity by Type (2018-2029)
7.2 North America Activin-A Sales Quantity by Application (2018-2029)
7.3 North America Activin-A Market Size by Country
7.3.1 North America Activin-A Sales Quantity by Country (2018-2029)
7.3.2 North America Activin-A Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Activin-A Sales Quantity by Type (2018-2029)
8.2 Europe Activin-A Sales Quantity by Application (2018-2029)
8.3 Europe Activin-A Market Size by Country
8.3.1 Europe Activin-A Sales Quantity by Country (2018-2029)
8.3.2 Europe Activin-A Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Activin-A Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Activin-A Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Activin-A Market Size by Region
9.3.1 Asia-Pacific Activin-A Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Activin-A Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Activin-A Sales Quantity by Type (2018-2029)
10.2 South America Activin-A Sales Quantity by Application (2018-2029)
10.3 South America Activin-A Market Size by Country
10.3.1 South America Activin-A Sales Quantity by Country (2018-2029)
10.3.2 South America Activin-A Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Activin-A Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Activin-A Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Activin-A Market Size by Country
11.3.1 Middle East & Africa Activin-A Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Activin-A Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Activin-A Market Drivers
12.2 Activin-A Market Restraints
12.3 Activin-A Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Activin-A and Key Manufacturers
13.2 Manufacturing Costs Percentage of Activin-A
13.3 Activin-A Production Process
13.4 Activin-A Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Activin-A Typical Distributors
14.3 Activin-A Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Activin-A Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Activin-A Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Millipore Basic Information, Manufacturing Base and Competitors
Table 4. Merck Millipore Major Business
Table 5. Merck Millipore Activin-A Product and Services
Table 6. Merck Millipore Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Millipore Recent Developments/Updates
Table 8. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 9. Thermo Fisher Scientific Major Business
Table 10. Thermo Fisher Scientific Activin-A Product and Services
Table 11. Thermo Fisher Scientific Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Thermo Fisher Scientific Recent Developments/Updates
Table 13. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 14. Bio-Techne Major Business
Table 15. Bio-Techne Activin-A Product and Services
Table 16. Bio-Techne Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bio-Techne Recent Developments/Updates
Table 18. StemRD Basic Information, Manufacturing Base and Competitors
Table 19. StemRD Major Business
Table 20. StemRD Activin-A Product and Services
Table 21. StemRD Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. StemRD Recent Developments/Updates
Table 23. Prospec Basic Information, Manufacturing Base and Competitors
Table 24. Prospec Major Business
Table 25. Prospec Activin-A Product and Services
Table 26. Prospec Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Prospec Recent Developments/Updates
Table 28. Proteintech Group Basic Information, Manufacturing Base and Competitors
Table 29. Proteintech Group Major Business
Table 30. Proteintech Group Activin-A Product and Services
Table 31. Proteintech Group Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Proteintech Group Recent Developments/Updates
Table 33. Ajinomoto Basic Information, Manufacturing Base and Competitors
Table 34. Ajinomoto Major Business
Table 35. Ajinomoto Activin-A Product and Services
Table 36. Ajinomoto Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Ajinomoto Recent Developments/Updates
Table 38. Enzo Life Sciences Basic Information, Manufacturing Base and Competitors
Table 39. Enzo Life Sciences Major Business
Table 40. Enzo Life Sciences Activin-A Product and Services
Table 41. Enzo Life Sciences Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Enzo Life Sciences Recent Developments/Updates
Table 43. IBL Basic Information, Manufacturing Base and Competitors
Table 44. IBL Major Business
Table 45. IBL Activin-A Product and Services
Table 46. IBL Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. IBL Recent Developments/Updates
Table 48. STEMCELL Basic Information, Manufacturing Base and Competitors
Table 49. STEMCELL Major Business
Table 50. STEMCELL Activin-A Product and Services
Table 51. STEMCELL Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. STEMCELL Recent Developments/Updates
Table 53. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 54. Sino Biological Major Business
Table 55. Sino Biological Activin-A Product and Services
Table 56. Sino Biological Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Sino Biological Recent Developments/Updates
Table 58. PeproTech Basic Information, Manufacturing Base and Competitors
Table 59. PeproTech Major Business
Table 60. PeproTech Activin-A Product and Services
Table 61. PeproTech Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. PeproTech Recent Developments/Updates
Table 63. ReproCELL Basic Information, Manufacturing Base and Competitors
Table 64. ReproCELL Major Business
Table 65. ReproCELL Activin-A Product and Services
Table 66. ReproCELL Activin-A Sales Quantity (mg), Average Price (US$/mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. ReproCELL Recent Developments/Updates
Table 68. Global Activin-A Sales Quantity by Manufacturer (2018-2023) & (mg)
Table 69. Global Activin-A Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Activin-A Average Price by Manufacturer (2018-2023) & (US$/mg)
Table 71. Market Position of Manufacturers in Activin-A, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Activin-A Production Site of Key Manufacturer
Table 73. Activin-A Market: Company Product Type Footprint
Table 74. Activin-A Market: Company Product Application Footprint
Table 75. Activin-A New Market Entrants and Barriers to Market Entry
Table 76. Activin-A Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Activin-A Sales Quantity by Region (2018-2023) & (mg)
Table 78. Global Activin-A Sales Quantity by Region (2024-2029) & (mg)
Table 79. Global Activin-A Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Activin-A Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Activin-A Average Price by Region (2018-2023) & (US$/mg)
Table 82. Global Activin-A Average Price by Region (2024-2029) & (US$/mg)
Table 83. Global Activin-A Sales Quantity by Type (2018-2023) & (mg)
Table 84. Global Activin-A Sales Quantity by Type (2024-2029) & (mg)
Table 85. Global Activin-A Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Activin-A Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Activin-A Average Price by Type (2018-2023) & (US$/mg)
Table 88. Global Activin-A Average Price by Type (2024-2029) & (US$/mg)
Table 89. Global Activin-A Sales Quantity by Application (2018-2023) & (mg)
Table 90. Global Activin-A Sales Quantity by Application (2024-2029) & (mg)
Table 91. Global Activin-A Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Activin-A Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Activin-A Average Price by Application (2018-2023) & (US$/mg)
Table 94. Global Activin-A Average Price by Application (2024-2029) & (US$/mg)
Table 95. North America Activin-A Sales Quantity by Type (2018-2023) & (mg)
Table 96. North America Activin-A Sales Quantity by Type (2024-2029) & (mg)
Table 97. North America Activin-A Sales Quantity by Application (2018-2023) & (mg)
Table 98. North America Activin-A Sales Quantity by Application (2024-2029) & (mg)
Table 99. North America Activin-A Sales Quantity by Country (2018-2023) & (mg)
Table 100. North America Activin-A Sales Quantity by Country (2024-2029) & (mg)
Table 101. North America Activin-A Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Activin-A Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Activin-A Sales Quantity by Type (2018-2023) & (mg)
Table 104. Europe Activin-A Sales Quantity by Type (2024-2029) & (mg)
Table 105. Europe Activin-A Sales Quantity by Application (2018-2023) & (mg)
Table 106. Europe Activin-A Sales Quantity by Application (2024-2029) & (mg)
Table 107. Europe Activin-A Sales Quantity by Country (2018-2023) & (mg)
Table 108. Europe Activin-A Sales Quantity by Country (2024-2029) & (mg)
Table 109. Europe Activin-A Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Activin-A Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Activin-A Sales Quantity by Type (2018-2023) & (mg)
Table 112. Asia-Pacific Activin-A Sales Quantity by Type (2024-2029) & (mg)
Table 113. Asia-Pacific Activin-A Sales Quantity by Application (2018-2023) & (mg)
Table 114. Asia-Pacific Activin-A Sales Quantity by Application (2024-2029) & (mg)
Table 115. Asia-Pacific Activin-A Sales Quantity by Region (2018-2023) & (mg)
Table 116. Asia-Pacific Activin-A Sales Quantity by Region (2024-2029) & (mg)
Table 117. Asia-Pacific Activin-A Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Activin-A Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Activin-A Sales Quantity by Type (2018-2023) & (mg)
Table 120. South America Activin-A Sales Quantity by Type (2024-2029) & (mg)
Table 121. South America Activin-A Sales Quantity by Application (2018-2023) & (mg)
Table 122. South America Activin-A Sales Quantity by Application (2024-2029) & (mg)
Table 123. South America Activin-A Sales Quantity by Country (2018-2023) & (mg)
Table 124. South America Activin-A Sales Quantity by Country (2024-2029) & (mg)
Table 125. South America Activin-A Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Activin-A Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Activin-A Sales Quantity by Type (2018-2023) & (mg)
Table 128. Middle East & Africa Activin-A Sales Quantity by Type (2024-2029) & (mg)
Table 129. Middle East & Africa Activin-A Sales Quantity by Application (2018-2023) & (mg)
Table 130. Middle East & Africa Activin-A Sales Quantity by Application (2024-2029) & (mg)
Table 131. Middle East & Africa Activin-A Sales Quantity by Region (2018-2023) & (mg)
Table 132. Middle East & Africa Activin-A Sales Quantity by Region (2024-2029) & (mg)
Table 133. Middle East & Africa Activin-A Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Activin-A Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Activin-A Raw Material
Table 136. Key Manufacturers of Activin-A Raw Materials
Table 137. Activin-A Typical Distributors
Table 138. Activin-A Typical Customers
List of Figures
Figure 1. Activin-A Picture
Figure 2. Global Activin-A Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Activin-A Consumption Value Market Share by Type in 2022
Figure 4. Activin-A Human Examples
Figure 5. Activin-A Mouse(Rat) Examples
Figure 6. Global Activin-A Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Activin-A Consumption Value Market Share by Application in 2022
Figure 8. Commercial Research Examples
Figure 9. Academic Research Examples
Figure 10. Global Activin-A Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Activin-A Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Activin-A Sales Quantity (2018-2029) & (mg)
Figure 13. Global Activin-A Average Price (2018-2029) & (US$/mg)
Figure 14. Global Activin-A Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Activin-A Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Activin-A by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Activin-A Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Activin-A Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Activin-A Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Activin-A Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Activin-A Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Activin-A Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Activin-A Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Activin-A Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Activin-A Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Activin-A Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Activin-A Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Activin-A Average Price by Type (2018-2029) & (US$/mg)
Figure 29. Global Activin-A Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Activin-A Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Activin-A Average Price by Application (2018-2029) & (US$/mg)
Figure 32. North America Activin-A Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Activin-A Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Activin-A Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Activin-A Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Activin-A Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Activin-A Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Activin-A Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Activin-A Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Activin-A Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Activin-A Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Activin-A Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Activin-A Consumption Value Market Share by Region (2018-2029)
Figure 52. China Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Activin-A Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Activin-A Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Activin-A Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Activin-A Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Activin-A Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Activin-A Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Activin-A Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Activin-A Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Activin-A Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Activin-A Market Drivers
Figure 73. Activin-A Market Restraints
Figure 74. Activin-A Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Activin-A in 2022
Figure 77. Manufacturing Process Analysis of Activin-A
Figure 78. Activin-A Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
